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Summary
In previous studies, we have reported that after chemotactic factor stimulation, PMNs from neonates
fail to undergo certain critical activation steps. Furthermore, the concentration offree intracellular
calcium reached is significantly below that of PMNs from adults . Interferon-y (IFN-'y) is a
lymphokine that has been shown to activatephagocyytc cells, and IFN-y messengerRNA production
by neonatal mononuclear leukocytes has been reported to be depressed. In the present studies,
we found that recombinant human IFN-y markedly enhanced the chemotactic responses ofPMNs
from neonates to levels that were not different from that ofPMNs from adults. Furthermore,
preincubation of the neonatal cells with this recombinant human lymphokine also corrected the
abnormality in intracellular calcium metabolism . These results suggest that this developmental
defect in phagoctic cell movement may be the result of an intrinsic defect in IFN-y production
resulting in deficiency of this critical phagocyte-activating lymphokine .
Although anumber of abnormalities in the neonate's host
11 defense system have been described, one of the most
consistent defects is in the ability of the PMNs from neo-
nates tomove in a unidirectional fashion toward a chemotactic
stimulus (1-5) . In previous studies, we reported in thisjournal
(1) that PMNs from neonates fail to increase their intracel-
lular concentration of free calcium to levels approximating
that of PMNs from adults after chemotactic factor stimula-
tion. This deficiency in signal transduction may contribute
to the defect in cell movement as well as the failure of these
cells to upregulate surface expression of the adhesive glyco-
protein CD 11b/18 complex and polymerize globular into
filaments actin (6, 7, 8) .
Interferon y is a glycoprotein varying in molecular mass
between 20 and 25 kD, depending on the degree of glycosy-
lation, encoded for by a single gene on chromosome 12 in
the human . It is produced by CD4+ and CD8+ T cells as
well as natural killer cells. Production ofIFN-y by neonatal
mononuclear cells has been reported to be decreased by sev-
eral investigators (9-12) . Recently, Ezekowitz et al . (13, 14)
have reported thatIFN-y treatment of patients with chronic
granulomatous disease of childhood (CGD) enhances phago-
cyte respiratory burst activity and significantly decreases these
patient's relative risk for acquiring serious infection. For these
reasons, we have examined the effect ofrecombinant human
IFN-y (rhIFN-y) on the responses of PMNs from human
neonates.
Materials and Methods
Polymorphonuclear Leukocyte Preparations.
￿
Whole blood was ob-
tained from peripheral veins of healthy adults and term neonates
as well as from umbilical veins in acid citrate dextrose (Becton Dick-
inson&Co., Mountain View, NJ) . The blood was allowed to settle
in 1% dextran (Pharmacia Fine Chemicals, Piscataway, NJ), and
the PMNs were separated on Ficoll-Hypaque (Pharmacia Fine
Chemicals) gradients. Contaminating erythrocytes were hypoton-
ically lysed, and the PMN suspensions (98% pure) were washed
in PBS (pH 7.4) . The cells were resuspended in a modified HBSS
as previously described (1) .
Changes in Intracellular Free Calcium .
￿
Changes in intracellular
free calcium were monitored spectrofluorometrically using the cal-
cium sensitiveprobe Indo-1. Indo-1AM (Molecular Probes, Eugene,
OR) in a 5-PM concentration was incubated with thePMNs with
rotation for 10 min at 37°C. The cells were then washed twice
in modifiedHBSS and resuspended in the same medium at a con-
centration of 5 x 106/ml . Spectrofluorescence was monitored at
10-s intervals for 60 s in a spectrofluorometer (SLM-Aminco, Ur-
bana, IL) with the excitation wave length set at 355 nm and emis-
sion wave lengths of 405 and 485 nm. Baseline fluorescence was
established at both emission wave lengths before FMLP (10-' M)
(Sigma Chemical Co ., St . Louis, MO) was added to the suspen-
sions . Changes in intracellular calcium were determined from the
ratio of emissions at 405 and 485 nm (15) . The baseline intracel-
lular free calcium concentration in PMNs is -50 ± 7 nM. There
was no difference in baseline values between PMNs from adults
and neonates . In the experiments with IFN - 'y, the cells were prein-
cubated with the indicated concentration ofrhIFN-y (Genentech,
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incubated PMNs from neonates and adults with other cytokines :
IFN-cx (Roche Pharmaceuticals, Nutley, NJ); IFN-R (Triton Bio-
sciences, Emeryville, CA); granulocyte/macrophage (GM)-CSF
(ICN Biochemicals, Cleveland,OH); G-CSF (Amgen Biologicals,
Thousand Oaks, CA);TNF-a (Cetus Corp., Emeryville, CA) ; IIT1
(Genzyme, Boston, MA);and 11,8 (Amgen Biologicals, Thousand
Oaks, CA) in a similar manner and examined their chemotactic
responsiveness . All experiments were performed three times with
duplicate or usually triplicate determinations, andmeans and stan-
dard errors were calculated . The figures show the means and stan-
dard errors (bars) of the mean .
Chemotaxis Assay. Chemotaxis was assessed in multiwell
microchemotaxis chambers (Neuroprobe Inc., CabinJohn, MD)
with 5-1Am pore size micropore filters (Millipore Corp., Bedford,
MA) . 50 P .1 containing 105 PMNs were added to the top or cell
side of the chamber, and 10 -8 MFMLP or recombinant human
C5a (100 ng/ml ; Sigma Chemical Co., St . Louis, MO) was added
to the bottom .
The chambers were incubated for 2 h at 37°C in a humidified
chamber with 5% added COz . Filters were removed, dried in al-
cohol, and stained with hematoxylin . ThePMNs that hadmigrated
completely through the filter in 10 random fields were counted
employing a 10x ocular, 45x objective, and a 5 x 5-mm photo-
graphic reticule. Three and five replicates were run for each vari-
able, and the mean wasdetermined . The person reading the slides
was blinded to the experimental protocol in all instances .
Interferon-y.
￿
rIFN-y (Genentech) cloned in Escherichia coli was
supplied as an endotoxin free lyophil containing 2 x 10' U/mg
protein . The lyophilized material was diluted in modified HBSS,
aliquoted, and stored at 4°C until use.
Interferon-ymAb .
￿
MurinemAbto humanIFN-,ywaspurchased
from Chemicon International (Los Angeles, CA) . The antibody
is an IgG2a monomer that neutralizes tit x 104 U/ml.
Statistical Analyses.
￿
Statistical analyses were carried out using
the unpaired student's t test .
Results
The mean number ofPMNs from 10 neonates migrating
completely through the filter in 10 random fields was 38 ±
5 compared with 73 ± 6 in 11 adults (Fig. 1 ; p < 0.02) .
We next examined the chemotactic responsiveness ofPMNs
from neonates after preincubation for 15min with 0.01 U/ml
of rhIFN-y . As shown (Fig . 1), the chemotactic response
of thePMNs from neonates increased significantly to a level
(63 t 9 PMNs/10 high power fields ; 166%) that was not
statistically different from that ofuntreatedPMNs from adults.
Adult PMNs incubated with IFN-y also had enhanced re-
sponses (99 ± 13) but the increase was not statistically
significant .
As added controls, we examined the effect of incubating
PMNs from three neonates and three adults with similar con-
centrations of seven additional cytokines . The data in Table
1 are derived from three separate experiments using different
donors. In these studies, onlyIFN-y (156% ;p = 0.002) and
GCSF (124% ;p = 0.04) enhanced the chemotaxis ofPMNs
from neonates . In contrast, IIr1 (78% ; p = 0.05) and 11,8
(70% ;p = 0.04) mildly suppressed movement of these cells .
AdultPMNs also had enhanced responsiveness after incuba-
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Figure 1.
￿
Chemotactic responses of the PMNs of 10 neonates and 11
adults to FMLP (10-8M) . Recombinant human IFN-,y (0.01U/ml) was
preincubated with the cells for 15 min . The differences between the un-
treated PMNs from neonates and adults was significant with a p value
of <0.02 employing the unpaired T test .
tion with IFN-,y but again the difference was not statisti-
cally significant (116%; p = 0.21) .
The increase in chemotactic responsiveness after incuba-
tion with IFN-y by the PMNs from neonates was dose de-
pendent with enhancement occurring at concentrations from
0.001 to 1 U/ml (Fig . 2) . Concentrations >1 U produced
(10-10,000 U) a plateau in the response .
Neonatal PMNs as well as PMNs from adults were in-
cubated with IFN-y (0.01 U/ml) for 1, 2, 5, 15, 30, and
60 min, washed, and examined for chemotactic responsive-
ness to FMLP. In these experiments, no effect was observed
after 1 min, but enhancement was prominent (219%) after
only2min ofexposure of the neonatal PMNs to the IFN-y .
In these experiments, themaximum response (465% ofbase-
line FMLP-stimulated chemotaxis) occurred after 15 min of
incubation with IFN-y .
We also attempted to determine how long the IFN- ,y en-
hancement of neonatalPMN chemotaxis persisted. Cells were
exposed to the IFN-y for 15 min, washed, and held at room
temperature for 60 and 120 min . In two experiments with
eight replicates per assay, enhancement persisted at 60 (205%)
but not 120 min (102%) .
Table 1 .
￿
Effect of Additional Cytokines on the Chemotactic
Responses ofPMNs from Neonates (n = 3) and Adults (n = 3)
to FMLP (10-8 M)
Data represent means ± SE .
Concentration 0.01 U/ml of cytokine .
Cytokine"
Neonatal PMNs/
10 hpf (p)
Adult PMNs/
10 hpf (p)
Medium 199 25.1 ± 1 .4 53 .1 ± 5.4
IFN-,y 39.1 ± 3 .7 (0.002) 61 .5 ± 3.9 (0.21)
IFN-ac 28.6 ± 1 .6 (0.12) 56.4 t 7.0 (0.71)
IFN-0 28.9 ± 2.2 (0.15) 52 .8 t 5.8 (0.97)
GM-CSF 21.8 t 2.6 (0.23) 49 .6 t 5.0 (0.65)
G-CSF 31.3 t 2.7 (0.04) 49.8 ± 3.0 (0.61)
TNF-cx 21.5 t 2.2 (0.16) 43 .9 ± 4.7 (0.22)
IL-1 19.5 ± 2.4 (0.05) 49 .7 ± 6.7 (0.23)
IL-8 17.4 t 4.2 (0.04) 43 .2 t 4.6 (0.30)LL
a
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Figure 2 .
￿
Effect ofdifferent concentrations ofrhIFN-y on neonatalPMN
chemotactic responses to FMLP (10_8 M) . IFN-y was preincubated with
the cells for 15 min at 37°C. Statistical differences between baseline with
mediaalone and the different concentrations ofIFWy were calculated using
the unpaired T test .
The enhancing effect of IFN-'y on neonatal PMN
chemotaxis was not limited to studies in which FMLP was
used as the chemoattractant . Enhancement was also observed
when recombinant human C5a was used as the chemoattrac-
tant . In additional experiments, PMNs from eight neonates
were examined . In the absence of IFN-y, C5a (100 ng/ml)
attracted an average of 16.8 ± 1.1 PMNs per 10 hpf . After
incubation with IFN-y (0.01 U/ml), the response increased
to 25.2 ± 1.8 (150%) (p = 0.001) .
We next examined the effects of IFN-y on chemotactic
factor (FMLP)-induced changes in free intracellular calcium
using the fluorescent calcium probe Indo-1AM . The rise in
intracellular calcium measured with Indo-1 after chemotactic
factor exposure of the PMNs from eight neonates (180 ±
5% ofbaseline) was significantly less than with PMNs from
nine adults (200 ± 4% ofbaseline; p < 0.05) . After incuba-
tion of the cells from neonates with 0.01 U of IFN-y, the
calcium response of the PMNs from neonates rose dramati-
cally to a level equivalent to that of the adult cells exposed,
or not exposed, to the lymphokine (Fig. 3) . Of the other
cytokines tested, onlyGCSF, which like IFN-y also enhanced
neonatal PMN chemotaxis, increased the calcium response
(135% ; data not shown) .
Additional experiments were carried out with the PMNs
from three neonates to determine the specificity ofthe IFN-'v
response . One U of anti-IFN-y mAb was incubated with
1 U of the rhIFN-y for 30 min before addition to neonatal
PMNs . The antibody inhibited rhIFN-y induced enhance-
ment in chemotaxis (Baseline 21.2 ± 2.1 PMNs/10 hpf vs.
37.9 ± 5.5 PMNs/10 hpf with IFN-y vs . 27.1 ± 2.7 with
IFN-y plus IFN-y mAb) .
Chemotaxis of the PMNs of neonates is significantly
depressed compared with PMNs from adults, and the intra-
cellular free calcium response is also blunted . IFN-'r appears
to correct not only the movement defect but also improves
the calcium response. Kemmerich et al . (16) reported that
IFN-y enhancedCon A-induced rises in free intracellular cal-
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Figure 3 .
￿
Effect of rhIFN on FMLP (10-8 M) induced changes in in-
tracellular free calcium as measured by Indo-1 fluorescence. IFN-'Y was
preincubated with the cells for 15 min. The baseline intracellular free cal-
cium concentration is -50 nM (± 7 nM) . There was no difference in
baseline values between PMNs from adults and neonates. As shown, stimu-
lated calcium concentrations increased from 180 to 210% of baseline in
neonatal and adult PMNs, respectively (90 and 105 nM, respectively) .
cium in peripheral blood monocytes from adults . Studies em-
ploying TMB-8, which prevents the release of intracellular
calcium, suggested that the IFN-y exerted its effect by in-
creasing the release of these stores rather than increasing the
influx of calcium . In our previous studies (1), we showed
that the rise in intracellular calcium associated with chemotactic
factor stimulation comes mostly from intracellular stores since
the rise occurred in both adult and neonatal PMNs in the
absence of extracellular calcium . This ability to enhance the
release ofintracellular calcium may partially explain the mech-
anism of IFN-y correction of the cell movement defect in
the PMNs of neonates .
Several investigators (9-12) have demonstrated that neo-
natal lymphocytes are strikingly deficient in their ability to
make IFN-y in response to a variety of stimuli. This is in
contrast to their ability to make other lymphokines such as
IL -2 (17) . The defect in IFN-y production by neonatal lym-
phocytes may be a critical one in host resistance not only
to viral infections like herpesvirus and cytomegalovirus but
also to pyogenic bacterial infections in which phagocyte acti-
vation, movement, and bactericidal activity are critical .
Ezekowitz et al . (14) in a recent double-blind placebo-
controlled trial have shown a dramatic effect of rhIFN-y, ad-
ministered subcutaneously in a dose of 50 mcg/m2 three
times per wk, to significantly decrease the relative risk of
serious infection in patients with CGD of childhood . Sur-
prisingly, in contrast to pilot study data (13), the CGD trial
failed to establish a consistent IFN-y effect on oxidative me-
tabolism ofPMNs from patients as measured by superoxide
production . Clearly, other mechanisms must be involved .
Human neonates have an increased susceptibility to serious
bacterial infection, including ones that are common in pa-
tients with classic PMN disorders such as CGD (cutaneous
infections with bacteria and yeast, pneumonia, and tissue in-
fections) . Furthermore, they clearly have defects in neutro-
phil movement and may have deficient bactericidal activity
under conditions of stress (18) . Studies by Sacchi et al. (7,19) suggest that this defect in cell movement and activation
persists for between 2 and 6 wk after birth, a period when
the infant is at highest risk for infection . Only through efforts
at enhancing the infant's own host defense system arewe likely
to continue to lower the morbidity and mortality due to in-
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fections in this age group . The present studies suggest that
rhIFN- ,y at concentrations easily achieved in the clinical set-
tingmay correct the major deficit in neonatal PMN function
in vitro. These data suggest the need for further investiga-
tions of the effects ofIFN-'y on host defenses in the neonate .
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